Sport Investors League
  • Politics
  • Stocks
  • Investing
  • Business

Sport Investors League

  • Politics
  • Stocks
  • Investing
  • Business
Stocks

DexCom Stock Rises From the Ashes: A Breakout You Can’t Ignore

by admin January 18, 2025
January 18, 2025
DexCom Stock Rises From the Ashes: A Breakout You Can’t Ignore

As advancements in medical technology continue to shape the healthcare landscape, DexCom, Inc. (DXCM) stands out with its innovative continuous glucose monitoring solutions. Recent price action suggests that DXCM’s stock price has triggered a potentially new bullish run. In this article, I will examine the technical and fundamental factors behind this positive outlook and outline a risk-defined options strategy — all identified via the OptionsPlay Strategy Center within StockCharts.com.

After consolidating between $75 and $80 over the past two months, DXCM’s stock price recently broke out of this trading range with impressive relative strength.

  • Range Breakout. The stock’s breakout above $80 marks a decisive breakout from its consolidation zone.
  • Outperformance. The breakout has been coupled with outperformance to the S&P 500.
  • Upside Target. Given the breakout, there is potential for DXCM’s stock price to fill the gap up to the $107.50 level.

FIGURE 1. DAILY CHART OF DXCM STOCK. The stock price traded between $75 and $80 since the end of November. DXCM recently broke out of its consolidation zone and traded above $80.Chart source: StockCharts.com. For educational purposes.

Beyond the charts, DXCM’s fundamentals support its premium valuation:

  • Premium but justified. While trading at 39x forward earnings, DXCM’s superior growth expectations and higher net margins than peers suggest that this valuation is justified.
  • Potential for substantial upside. Robust demand in the continuous glucose monitoring market and DexCom’s leadership position the company to capitalize on ongoing trends. The combination of strong growth prospects and healthy margins provides the potential for further appreciation.

Options Strategy

Based on this bullish thesis, the OptionsPlay Strategy Center highlights a bull put spread.

  • Sell: February 28, 2025, $84 Put at $5.40
  • Buy: February 28, 2025, $77 Put at $2.42
  • Net Credit: $2.98 per share (or $298 total per contract, since each contract represents 100 shares)

FIGURE 2. DXCM BULL PUT SPREAD RISK CURVE.

Trade Details

  • Maximum Potential Reward: $298
  • Maximum Potential Risk: $402
  • Breakeven Point: $81.02
  • Probability of Profit: 58.58%

This strategy benefits from time decay and a bullish outlook, providing limited risk and a defined reward. At expiration, profits are earned if DXCM’s stock price remains above the breakeven level.

Unlock Real-Time Trade Ideas

This bullish trade in DXCM was identified using the OptionsPlay Strategy Center within StockCharts.com. The platform’s Bullish Outperform scan (see below) automatically flagged DXCM as the best candidate for selling a Bull Put Spread out of the many stocks currently outperforming the market, then structured the optimal options trade — helping you save hours of research.

FIGURE 3. BULLISH OUTPERFORMANCE SCAN. DXCM was identified as a candidate for a bull put spread.


By subscribing to the OptionsPlay Strategy Center, you gain access to:

  •  Automated Market Scans. Quickly discover high-probability trading opportunities based on technical and fundamental signals.
  • Optimal Trade Structuring. Receive tailored, real-time options strategies for your market outlook and risk tolerance.
  • Time-Saving Insights. Make informed decisions faster, avoiding the time-consuming process of manual analysis.

Don’t miss out on your next high-conviction idea. Subscribe to the OptionsPlay Strategy Center today and unlock a streamlined approach to uncovering the best options trades—all within seconds, every single day. Let OptionsPlay be your strategic ally in navigating the markets efficiently and effectively.

0
FacebookTwitterGoogle +Pinterest
previous post
Treasury Department recoups $31 million in improper government payments to dead people
next post
Tech 5: Trump to Prioritize Crypto, Biden Blocks AI Chip Exports

Related Posts

TIME TO USE YOUR DISCRETION AS SECTOR HELPS...

July 16, 2024

Which Top AI Semiconductor Stocks are Positioned for...

January 8, 2025

Is the Trump Rally Like the Reagan Rally?

November 12, 2024

Recession Ahead? Sector Rotation Model Warns of Rising...

May 11, 2025

These 4 Chinese Stocks are Worth a Look

October 3, 2024

S&P 500 Breakdown Alert! Downside Targets Explained

January 11, 2025

MACD Crossovers: Why Most Traders Get It Wrong

July 3, 2025

Market Chaos: How to Spot Bottoming Stocks Before...

February 15, 2025

Three Stocks to Watch: Utilities, Banks, Airlines

April 5, 2025

Does the MACD Histogram Hold the Secret to...

October 19, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent

    • Israel slams UN for ignoring aid already in Gaza while demanding more

      July 16, 2025
    • Trump accuses ‘scam artist’ Schiff of lying about Maryland home to commit mortgage fraud

      July 16, 2025
    • House GOP subpoenas Biden aide to testify about former president’s concerning mental fitness

      July 16, 2025
    • Democrats capitalize on GOP Jeffrey Epstein fallout with new demands for Jim Jordan

      July 16, 2025
    • Senate GOP agree to strip cuts to HIV, AIDS prevention program from Trump’s clawback bill

      July 16, 2025

    Categories

    • Business (1,023)
    • Investing (2,617)
    • Politics (3,233)
    • Stocks (1,136)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sportinvestorsleague.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 sportinvestorsleague.com | All Rights Reserved